Downregulation of BACE1-AS inhibited the activation of iNOS in the substantial nigra by upregulating miR-34b-5p and downregulating BACE1, and then improved oxidative stress damage of rats with Parkinson’s disease (63). This evidence concerns the gene BACE1 and Parkinson disease.